RTR TECHNOVATION

Our mission is to develop novel technologies that diagnose and treat chronic disease states. We do this by researching rare cases of disease remission and ultimately mimicking those responses. To achieve this, our first product, Mivatana TM, is a versatile intravenous nanoparticle platform for diagnostic and therapeutic use. Its unique design enables the earliest and most sensitive detection and targeting of disease-prone blood vessels, associated with various chronic diseases, such as heart disease, cancer, and diabetes.

Primary location: Chino United States